Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

March 4, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions

COVID-19 Pneumonia

Interventions

DRUG

EG-009A

Administered as an Intramuscular injection

DRUG

EG-009A Placebo

Administered as an Intramuscular injection

DRUG

Standard of Care

Standard of Care Treatment for COVID-19 Infection

DRUG

Dexamethasone

The comparator, Administered as an Intravenous infusion